News/ News/ Oncology Catamaran joins the CAR-NK fleet, raising $42m in first round Phil Taylor Biotech, blood cancers, car-nk, Catamaran Bio, cell therapy, immuno-oncology, Oncology, solid tumours 0 Comment Catamaran Bio has weighed anchor with a $42 million first-round financing that will be used to pull its Share X Catamaran joins the CAR-NK fleet, raising $42m in first round https://pharmaphorum.com/news/catamaran-joins-the-car-nk-fleet-raising-42m-in-first-round/